2025年他克莫司正版的价格是多少？

Tacrolimus is an immunosuppressant that is widely used to prevent rejection after organ transplantation and to treat certain autoimmune diseases. This article will discuss the price, medication preparation, and medication information for special groups of genuine tacrolimus in 2025, providing comprehensive guidance for patients and their families.

What is the genuine price of tacrolimus in 2025

Market status

With the advancement of medical technology and the intensification of market competition, the price of tacrolimus has changed to a certain extent. Although specific prices vary by region and sales channel, the overall trend is to stabilize or decline slightly.

For patients who require long-term use of tacrolimus, understanding the latest market price dynamics can help to better plan their treatment budget.

Price reference

The specification of Japan's Towa Pharmaceutical version of tacrolimus is 0.5mg*100 tablets/box, and the price is about US$110. The price is for reference only. When purchasing, you need to compare it with the specific quotation from local pharmacies.

Impact of medical insurance policy

In China, tacrolimus has been included in the national medical insurance catalog, and eligible patients can reimburse part of the cost through medical insurance, thereby reducing the financial burden. The specific reimbursement ratio and conditions will vary according to the medical insurance policies of different regions.

Patients are advised to consult their local medical insurance department to learn the detailed reimbursement process and requirements before purchasing.

Tacrolimus medication preparation

Prescription acquisition and physician guidance

Tacrolimus is a prescription drug that must be used under the guidance of a professional doctor. Patients should inform the doctor in detail about their medical history, allergies and other medications they are taking when seeking medical treatment, so that the doctor can issue appropriate prescriptions.

Following medical advice can not only improve the effectiveness of treatment, but also reduce unnecessary side effects.

Drug Storage and Management

Tacrolimus should be stored in a cool, dry place, away from direct sunlight, and out of the reach of children. The validity period of medicines is usually 36 months. You should carefully check the validity period on the packaging before use. Expired medicines should be disposed of in time.

Correct storage methods can ensure the quality and efficacy of medicines.

Monitoring and adjusting dosage

While using tacrolimus, it is very important to have regular blood tests to monitor blood drug concentrations. This helps to adjust the dose in time to avoid side effects caused by too high a drug concentration or treatment failure caused by too low a concentration.

Patients should follow the doctor’s recommendations for regular check-ups and adjust treatment plans based on test results.

Special population use of tacrolimus

Pregnant and lactating women

The use of tacrolimus in pregnant women may cause harm to the fetus, so pregnant women should avoid its use or have their doctor weigh the benefits and risks before deciding whether to use it after fully understanding the risks. Likewise, lactating women should use it with caution and discontinue breastfeeding if necessary.

In this case, the doctor will develop the most appropriate treatment plan based on the specific situation.

Geriatric patients

No significant safety differences were observed when using tacrolimus in patients aged ≥65 years, and dose adjustment is generally not required. However, elderly patients are more likely to experience drug-related adverse reactions due to reduced physiological functions, so their health status should be monitored more closely during medication.

The doctor will adjust the treatment plan according to the patient's actual condition.

Patients with hepatic and renal dysfunction

Patients with mild to moderate hepatic impairment or renal insufficiency do not need to adjust the dose of tacrolimus, but for patients with severe hepatic impairment or renal impairment, it should be used after careful evaluation and a dose reduction may be required.

Such patients should undergo a comprehensive evaluation before using tacrolimus and closely monitor relevant indicators during treatment.

By having a detailed understanding of the genuine price of tacrolimus in 2025, medication preparation, and medication information for special populations, patients and their families can better cope with various challenges during the treatment process, rationally arrange drug procurement, and follow doctors' recommendations to improve the success rate of treatment.